IMPROVE-BMT: A Pilot Randomized Controlled Trial of Prehabilitation Exercise for Adult Hematopoietic Stem Cell Transplant Recipients

IMPROVE-BMT: A Pilot Randomized Controlled Trial of Prehabilitation Exercise for Adult Hematopoietic Stem Cell Transplant Recipients

<b>Background</b>: There is limited evidence on the effects of aerobic and resistance training exercise interventions to improve physical function and patient-reported outcomes prior to autologous and allogeneic hematopoietic stem cell transplant (HSCT). IMPROVE-BMT was a single-site, pi...

Full description

Bibliographic Details
Main Authors:	Melanie Potiaumpai, Maxime Caru, Shin Mineishi, Seema Naik, Babette S. Zemel, Kathryn H. Schmitz
Format:	Article
Language:	English
Published:	MDPI AG 2024-04-01
Series:	Journal of Clinical Medicine
Subjects:	allogeneic stem cell transplant autologous stem cell transplant cancer exercise exercise oncology oncology
Online Access:	https://www.mdpi.com/2077-0383/13/7/2052

Similar Items

Hematopoietic Stem Cell Transplantation in Iran: 1991 through 2010
by: Ardeshir Ghavamzadeh, et al.
Published: (2010-10-01)

Hematopoietic Stem Cell Transplantation in Iran: 1991 through 2010
by: Ardeshir Ghavamzadeh, et al.
Published: (2010-12-01)

COVID-19 infection in hematopoietic stem cell transplant recipients
by: Siniaev A.A., et al.
Published: (2022-09-01)

Current status of hematopoietic stem cell transplantation in Russia
by: L. P. Mendeleeva, et al.
Published: (2022-11-01)

The benefit of exercise in patients who undergo allogeneic hematopoietic stem cell transplantation
by: Shinichiro Morishita, et al.
Published: (2019-01-01)

Physiological problems in patients undergoing autologous and allogeneic hematopoietic stem cell transplantation
by: Sevgisun Kapucu, et al.
Published: (2014-01-01)

Use of Plerixafor for Stem Cell Mobilization in the Setting of Autologous and Allogeneic Stem Cell Transplantations: An Update [Corrigendum]
by: Bilgin YM
Published: (2022-09-01)

Use of Plerixafor for Stem Cell Mobilization in the Setting of Autologous and Allogeneic Stem Cell Transplantations: An Update
by: Bilgin YM
Published: (2021-06-01)

Temporal trends in hematopoietic stem cell transplantation in Argentina between 2009 and 2018: A collaborative study by GATMO-TC and INCUCAI
by: Ana Lisa Basquiera, et al.
Published: (2023-04-01)

A Comparison of the Effect of Two Types of Continuous and Discontinuous Aerobic Exercise on Patients' Stem Cell Mobilization before Autologous Hematopoietic Stem Cell Transplantation
by: Kimia Kasravi, et al.
Published: (2021-01-01)

Exercise before, during, and after Hospitalization for Allogeneic Hematological Stem Cell Transplant: A Feasibility Randomized Controlled Trial
by: Daniel Santa Mina, et al.
Published: (2020-06-01)

Trends in Outcome of Hematopoietic Stem Cell Transplantation: 5000 Transplantations and 30 Years of Single-Center Experience
by: Ludmila Stepanovna Zubarovskaya, et al.
Published: (2023-09-01)

Comparative efficacy of tandem autologous versus autologous followed by allogeneic hematopoietic cell transplantation in patients with newly diagnosed multiple myeloma: a systematic review and meta-analysis of randomized controlled trials
by: Kharfan-Dabaja Mohamed A, et al.
Published: (2013-01-01)

Autologous and Allogeneic Hematopoetic Stem Cell Transplantation for Solid Tumors in Iran
by: Mohammad Jahani, et al.
Published: (2011-01-01)

Autologous and Allogeneic Hematopoetic Stem Cell Transplantation for Solid Tumors in Iran
by: Ardeshir Ghavamzadeh, et al.
Published: (2011-03-01)

Reappraising the Role of Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed and Refractory Hodgkin’s Lymphoma: Recent Advances and Outcomes
by: Taha Al-Juhaishi, et al.
Published: (2022-01-01)

Effective use of intensive treatment against multiple myeloma of recipient origin after allogeneic transplantation for acute myeloid leukemia
by: Félicité de Charry, et al.
Published: (2023-01-01)

THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
by: Francesco Maura, et al.
Published: (2016-09-01)

Describing symptoms using the Symptom Screening in Pediatrics Tool in hospitalized children with cancer and hematopoietic stem cell transplant recipients
by: Donna L. Johnston, et al.
Published: (2018-05-01)

Stem-Cell Transplantation in Adult Patients with Relapsed/Refractory Hodgkin Lymphoma
by: Sonja Genadieva Stavrik, et al.
Published: (2021-10-01)

Risk Factors and Outcome of <i>C. difficile</i> Infection after Hematopoietic Stem Cell Transplantation
by: Chiara Rosignoli, et al.
Published: (2020-11-01)

Human herpesvirus-6 in hematopoietic stem cell transplant recipients: a prospective cohort study in Egypt
by: May Moheb Eldin Raouf, et al.
Published: (2023-02-01)

SARS-CoV-2 Immunity in Hematopoietic Stem Cell Transplant and Cell Therapy Recipients: What Do We Know, and What Remains to Be Determined?
by: José Luis Piñana, et al.
Published: (2023-05-01)

Debating the Future of Sickle Cell Disease Curative Therapy: Haploidentical Hematopoietic Stem Cell Transplantation vs. Gene Therapy
by: Adetola A. Kassim, et al.
Published: (2022-08-01)

Preventing the adverse cardiovascular consequences of allogeneic stem cell transplantation with a multi-faceted exercise intervention: the ALLO-Active trial protocol
by: Hayley T. Dillon, et al.
Published: (2022-08-01)

Role of Stem Cell Transplantation in Multiple Myeloma
by: Srinivas Devarakonda, et al.
Published: (2021-02-01)

Stem Cell Transplantation in Iran; 1991 until 2009
by: Ali Khodabandeh, et al.
Published: (2009-01-01)

Stem Cell Transplantation in Iran; 1991 until 2009
by: Ardeshir Ghavamzadeh, et al.
Published: (2009-03-01)

Graft‐versus‐host disease after autologous stem cell transplantation in a recipient who underwent allogeneic stem cell transplantation 20 years earlier
by: Osamu Imataki, et al.
Published: (2024-04-01)

Changes in serologic markers of hepatitis B in autologous hematopoietic stem cell transplantation recipients
by: Mehmet Hilmi Dogu, et al.
Published: (2016-01-01)

Association of Patient-Reported Physical Activity on Allogeneic Hematopoietic Cell Transplant Outcomes
by: Reena V. Jayani, et al.
Published: (2021-03-01)

Gut Microbiota Influence in Hematological Malignancies: From Genesis to Cure
by: Mireia Uribe-Herranz, et al.
Published: (2021-01-01)

Autologous followed by allogeneic versus tandem-autologous transplantation in high-risk, newly diagnosed multiple myeloma: a systematic review and meta-analysis
by: Min Wei, et al.
Published: (2023-12-01)

Proteomics to predict relapse in patients with myelodysplastic neoplasms undergoing allogeneic hematopoietic cell transplantation
by: Guru Subramanian Guru Murthy, et al.
Published: (2024-01-01)

Allogeneic hematopoietic stem cell transplantation in patients with multiple myeloma
by: Maiia V. Firsova, et al.
Published: (2021-07-01)

Harvesting, processing and inventory management of peripheral blood stem cells
by: Mijovic Aleksandar, et al.
Published: (2007-01-01)

Allogeneic hematopoietic stem cell transplantation in Hodgkin lymphoma in Switzerland, 20 years of experience: 2001–2020
by: Helena Simeunovic, et al.
Published: (2023-02-01)

Lung transplantation for late-onset non-infectious chronic pulmonary complications of allogenic hematopoietic stem cell transplant
by: Peter Riddell, et al.
Published: (2021-04-01)

Autologous hematopoietic stem cell transplantation in progressive severe multiple sclerosis
by: Awadh Kishor Pandit, et al.
Published: (2015-01-01)

Thymopoiesis in Pre- and Post-Hematopoietic Stem Cell Transplantation
by: Luis Klaus A. da Rocha, et al.
Published: (2018-09-01)